Clinical Trial Update: Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of casein phosphopeptide-amorphous calcium phosphate on human enamel under in vivo acid attacks for dental erosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Erosion

Drugs mentioned

• casein phosphopeptide-amorphous calcium phosphate (casein phosphopeptide-amorphous calcium phosphate)

Snippet

Sponsor: Fujian Medical University | Conditions: Dental Erosion | Phase 4 | Status: COMPLETED